Literature DB >> 26219731

Exploring Value in Congenital Heart Disease: An Evaluation of Inpatient Admissions.

Andrew Y Shin1,2, Zhongkai Hu3, Bo Jin3, Sangeeta Lal1, David N Rosenthal1, Bradley Efron4, Paul J Sharek1,2, Scott M Sutherland1, Harvey J Cohen1, Doff B McElhinney5, Stephen J Roth1, Xuefeng B Ling3.   

Abstract

OBJECTIVES: Understanding value provides an important context for improvement. However, most health care models fail to measure value. Our objective was to categorize inpatient encounters within an academic congenital heart program based on clinical outcome and the cost to achieve the outcome (value). We aimed to describe clinical and nonclinical features associated with value.
DESIGN: We defined hospital encounters based on outcome per resource utilized. We performed principal component and cluster analysis to classify encounters based on mortality, length of stay, hospital cost and revenue into six classes. We used nearest shrunken centroid to identify discriminant features associated with the cluster-derived classes. These features underwent hierarchical clustering and multivariate analysis to identify features associated with each class. STUDY SETTING/PATIENTS: We analyzed all patients admitted to an academic congenital heart program between September 1, 2009, and December 31, 2012. OUTCOME MEASURES/
RESULTS: A total of 2658 encounters occurred during the study period. Six classes were categorized by value. Low-performing value classes were associated with greater institutional reward; however, encounters with higher-performing value were associated with a loss in profitability. Encounters that included insertion of a pediatric ventricular assist device (log OR 2.5 [95% CI, 1.78 to 3.43]) and acquisition of a hospital-acquired infection (log OR 1.42 [95% CI, 0.99 to 1.87]) were risk factors for inferior health care value.
CONCLUSIONS: Among the patients in our study, institutional reward was not associated with value. We describe a framework to target quality improvement and resource management efforts that can benefit patients, institutions, and payers alike.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital; Cost; Heart Defects; Length of Stay; Mortality; Value

Mesh:

Year:  2015        PMID: 26219731     DOI: 10.1111/chd.12290

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  1 in total

1.  Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan.

Authors:  Ho-Chang Kuo; Shiying Hao; Bo Jin; C James Chou; Zhi Han; Ling-Sai Chang; Ying-Hsien Huang; Kuoyuan Hwa; John C Whitin; Karl G Sylvester; Charitha D Reddy; Henry Chubb; Scott R Ceresnak; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Doff McElhinney; Harvey J Cohen; Xuefeng B Ling
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.